Joseph Wagner
Net worth: - $ as of 2024-04-29
Profile
Dr. Joseph P.
Wagner is a Chief Scientific Officer at Notable Labs Ltd.
Dr. Wagner was previously employed as a President, Chief Executive Officer & Director by BriaCell Therapeutics Corp., a President by Cell Targeting, Inc., a Vice President-Cellular Therapy by Neuronyx, Inc., and a Chief Executive Officer by OncoCyte Corp.
He received his undergraduate degree from Rochester Christian University and a doctorate degree from Duke University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 2024-05-07 | 0 ( -.--% ) | - $ | 2024-04-29 |
Joseph Wagner active positions
| Companies | Position | Start |
|---|
Former positions of Joseph Wagner
| Companies | Position | End |
|---|---|---|
| BRIACELL THERAPEUTICS CORP. | Chief Executive Officer | 2016-03-23 |
Neuronyx, Inc.
 Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Corporate Officer/Principal | 2009-10-12 |
Cell Targeting, Inc.
 Cell Targeting, Inc. BiotechnologyHealth Technology Part of Lineage Cell Therapeutics, Inc., Cell Targeting, Inc. is a private company that provides research and development of aqueous-based synthetic solutions. The company is based in Cleveland, OH. Cell Targeting was acquired by Lineage Cell Therapeutics, Inc. on January 28, 2011 for $2.38 million. | President | - |
| ONCOCYTE CORPORATION | Chief Executive Officer | - |
Training of Joseph Wagner
| Rochester Christian University | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ONCOCYTE CORPORATION | Health Technology |
| BRIACELL THERAPEUTICS CORP. | Health Technology |
| Private companies | 2 |
|---|---|
Neuronyx, Inc.
Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Health Technology |
Cell Targeting, Inc.
Cell Targeting, Inc. BiotechnologyHealth Technology Part of Lineage Cell Therapeutics, Inc., Cell Targeting, Inc. is a private company that provides research and development of aqueous-based synthetic solutions. The company is based in Cleveland, OH. Cell Targeting was acquired by Lineage Cell Therapeutics, Inc. on January 28, 2011 for $2.38 million. | Health Technology |
- Stock Market
- Insiders
- Joseph Wagner
